Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

Quantum Machine Learning: Revolutionizing Preclinical Drug Development for Targeted Therapies

Adegoke Ayuba, Lawrence Kelvin, Terry Tera

Published Nov 2, 2023• 0 citations
Publisher

Abstract

In the relentless pursuit of groundbreaking advancements in precision medicine, the harmonious amalgamation of quantum computing and machine learning stands as a formidable catalyst in the realm of preclinical drug development. This article endeavors to unveil the seismic shift instigated by Quantum Machine Learning (QML) and its profound ramifications on the inception of precision-targeted therapies. We embark on an exploration of the foundational tenets of quantum computing, its symbiotic integration with machine learning algorithms, and its multifaceted applications in the intricate landscape of preclinical drug discovery.

DOI
10.31219/osf.io/4xf5z

Related papers

Quantum Machine Learning: Revolutionizing Drug Discovery

Adegoke Ayuba, Lawrence Kelvin, Terry Tera

This article presents a compelling exploration into the transformative potential of Quantum Machine Learning (QML) in the realm of drug discovery. The main findings of this study underscore the profound impact of QML, as it offers a revolutionary approach to drug development. By synergizing quantum computing and machine learning, QML enables precision and efficiency at every stage of drug discovery. Its applications encompass target identification, molecular docking, pharmacokinetics prediction, toxicity assessment, and accelerated drug screening. The significance of these findings lies in the promise of expedited, cost-effective, and targeted drug development. The marriage of quantum computing and machine learning opens new frontiers for precision medicine and holds the potential to reshape the pharmaceutical landscape. This article delves into the foundational principles, real-world case studies, and ethical considerations surrounding the implementation of QML in drug discovery, illuminating its potential to revolutionize the field and improve patient outcomes.

•Nov 3, 2023•2 citations

Advancing Drug Discovery with Quantum Machine Learning

Rati Kailash Prasad Tripathi

At the forefront of innovation in drug discovery lies quantum machine learning (QML), poised to revolutionize the field with its unparalleled potential. Through the amalgamation of quantum computing and machine learning principles, QML presents novel solutions to complex computational challenges inherent in pharmaceutical research. The chapter explores the multifaceted applications of QML in drug discovery, including predictive modeling of pharmacokinetic and pharmacodynamic properties, personalized medicine, and precision drug design. Despite facing challenges, such as data quality and algorithm optimization, the future of QML in drug discovery is promising. As researchers continue to explore and refine QML techniques, they pave the way for enhanced therapeutic efficacy, optimized combination therapies, and tailored treatment strategies, ultimately advancing the field of drug discovery into new frontiers.

Auerbach Publications eBooks•Mar 3, 2025•1 citation

Revolutionizing Drug Discovery: Quantum-Based Machine Learning Simulation for Tomorrow's Medicine

Adegoke Ayuba, Terry Tera, Lawrence Kelvin

The pharmaceutical industry has reached a pivotal moment, where the integration of quantum computing and machine learning stands to redefine the drug discovery process. This article explores the implications of Quantum-Based Machine Learning Simulation (QMLS) and its potential to shape the future of medicine. We delve into the convergence of quantum computing, artificial intelligence, and drug development, highlighting the promising breakthroughs and challenges ahead.

•Nov 2, 2023•0 citations

Quantum Machine Learning in Drug Discovery

Adegoke Ayuba, Lawrence Kelvin, Terry Tera +1 more

This article explores the transformative potential of Quantum Machine Learning (QML) in drug discovery. QML leverages quantum computing and advanced machine learning to accelerate the identification of drug candidates, predict molecular interactions, and optimize compounds. Key applications include efficient virtual screening, molecular simulation, and predictive modeling. While promising, QML faces technical challenges, requiring collaboration between quantum experts and pharmaceutical researchers. In summary, QML offers a faster, cost-effective path to drug development, with the potential to reshape the pharmaceutical industry and advance medical science.

•Nov 7, 2023•2 citations

Quantum Computing and Machine Learning for Transforming Precision Medicine and Drug Discovery

Lakshmana Kumar Yenduri, M H Chaithra, Shahedhadeennisa Shaik +3 more

Quantum Machine Learning can be considered one of the transformational technologies in precision medicine and drug discovery because quantum computing combines immense processing power with high capability, predictive machine learning. This chapter will discuss the potential for QML to revolutionize complex biological data analysis to rapidly identify disease biomarkers and highly personalized treatment approaches. The chapter describes the two superior performances that can be achieved by quantum algorithms in simulating molecular interactions, and thereby drastically reducing time and cost in drug development. It also discusses key applications that include quantum-enhanced neural networks and support vector machines to diagnose diseases and predict outcomes of treatments. Challenges regarding scalability, noise reduction, and hardware limitations are discussed together with some very promising future directions. When quantum technology has reached full maturity, the opportunities it will give to machine learning will provide unparalleled breakthroughs in medical research.

Advances in computer and electrical engineering book series•Dec 13, 2024•2 citations

Unlocking the Potential of Quantum Machine Learning to Advance Drug Discovery

Maria Avramouli, Ilias Κ. Savvas, Anna Vasilaki +1 more

The drug discovery process is a rigorous and time-consuming endeavor, typically requiring several years of extensive research and development. Although classical machine learning (ML) has proven successful in this field, its computational demands in terms of speed and resources are significant. In recent years, researchers have sought to explore the potential benefits of quantum computing (QC) in the context of ML, leading to the emergence of Quantum Machine Learning (QML) as a distinct research field. The objective of the current study is twofold: first, to present a review of the proposed QML algorithms for application in the drug discovery pipeline, and second, to compare QML algorithms with their classical and hybrid counterparts in terms of their efficiency. A query-based search of various databases took place, and five different categories of algorithms were identified in which QML was implemented. The majority of QML applications in drug discovery are primarily focused on the initial stages of the drug discovery pipeline, particularly with regard to the identification of novel drug-like molecules. Comparison results revealed that QML algorithms are strong rivals against the classical ones and a hybrid solution is the recommended approach at present.

Electronics•May 25, 2023•42 citations
In the relentless pursuit of groundbreaking advancements in precision medicine, the harmonious amalgamation of quantum computing and machine learning stands as a formidable catalyst in the realm of preclinical drug development. This article endeavors to unveil the seismic shift instigated by Quantum Machine Learning (QML) and its profound ramifications on the inception of precision-targeted therapies. We embark on an exploration of the foundational tenets of quantum computing, its symbiotic integration with machine learning algorithms, and its multifaceted applications in the intricate landscape of preclinical drug discovery.
This article presents a compelling exploration into the transformative potential of Quantum Machine Learning (QML) in the realm of drug discovery. The main findings of this study underscore the profound impact of QML, as it offers a revolutionary approach to drug development. By synergizing quantum computing and machine learning, QML enables precision and efficiency at every stage of drug discovery. Its applications encompass target identification, molecular docking, pharmacokinetics prediction, toxicity assessment, and accelerated drug screening. The significance of these findings lies in the promise of expedited, cost-effective, and targeted drug development. The marriage of quantum computing and machine learning opens new frontiers for precision medicine and holds the potential to reshape the pharmaceutical landscape. This article delves into the foundational principles, real-world case studies, and ethical considerations surrounding the implementation of QML in drug discovery, illuminating its potential to revolutionize the field and improve patient outcomes.
At the forefront of innovation in drug discovery lies quantum machine learning (QML), poised to revolutionize the field with its unparalleled potential. Through the amalgamation of quantum computing and machine learning principles, QML presents novel solutions to complex computational challenges inherent in pharmaceutical research. The chapter explores the multifaceted applications of QML in drug discovery, including predictive modeling of pharmacokinetic and pharmacodynamic properties, personalized medicine, and precision drug design. Despite facing challenges, such as data quality and algorithm optimization, the future of QML in drug discovery is promising. As researchers continue to explore and refine QML techniques, they pave the way for enhanced therapeutic efficacy, optimized combination therapies, and tailored treatment strategies, ultimately advancing the field of drug discovery into new frontiers.
This article explores the transformative potential of Quantum Machine Learning (QML) in drug discovery. QML leverages quantum computing and advanced machine learning to accelerate the identification of drug candidates, predict molecular interactions, and optimize compounds. Key applications include efficient virtual screening, molecular simulation, and predictive modeling. While promising, QML faces technical challenges, requiring collaboration between quantum experts and pharmaceutical researchers. In summary, QML offers a faster, cost-effective path to drug development, with the potential to reshape the pharmaceutical industry and advance medical science.
Quantum Machine Learning can be considered one of the transformational technologies in precision medicine and drug discovery because quantum computing combines immense processing power with high capability, predictive machine learning. This chapter will discuss the potential for QML to revolutionize complex biological data analysis to rapidly identify disease biomarkers and highly personalized treatment approaches. The chapter describes the two superior performances that can be achieved by quantum algorithms in simulating molecular interactions, and thereby drastically reducing time and cost in drug development. It also discusses key applications that include quantum-enhanced neural networks and support vector machines to diagnose diseases and predict outcomes of treatments. Challenges regarding scalability, noise reduction, and hardware limitations are discussed together with some very promising future directions. When quantum technology has reached full maturity, the opportunities it will give to machine learning will provide unparalleled breakthroughs in medical research.
The drug discovery process is a rigorous and time-consuming endeavor, typically requiring several years of extensive research and development. Although classical machine learning (ML) has proven successful in this field, its computational demands in terms of speed and resources are significant. In recent years, researchers have sought to explore the potential benefits of quantum computing (QC) in the context of ML, leading to the emergence of Quantum Machine Learning (QML) as a distinct research field. The objective of the current study is twofold: first, to present a review of the proposed QML algorithms for application in the drug discovery pipeline, and second, to compare QML algorithms with their classical and hybrid counterparts in terms of their efficiency. A query-based search of various databases took place, and five different categories of algorithms were identified in which QML was implemented. The majority of QML applications in drug discovery are primarily focused on the initial stages of the drug discovery pipeline, particularly with regard to the identification of novel drug-like molecules. Comparison results revealed that QML algorithms are strong rivals against the classical ones and a hybrid solution is the recommended approach at present.